Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Lucy Scientific Discovery's Days Sales Outstanding or its related term are showing as below:
LSDIF's Days Sales Outstanding is not ranked *
in the Drug Manufacturers industry.
Industry Median: 71.98 * Ranked among companies with meaningful Days Sales Outstanding only.
Lucy Scientific Discovery's Days Sales Outstanding
increased
from Dec. 2022 (0.00) to Dec. 2023 (9.13).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lucy Scientific Discovery Days Sales Outstanding Chart
LSDIF vs INQD, ZTS, VTRS: Days Sales Outstanding Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Lucy Scientific Discovery's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lucy Scientific Discovery Days Sales Outstanding vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lucy Scientific Discovery's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Lucy Scientific Discovery's Days Sales Outstanding falls into.
Lucy Scientific Discovery Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lucy Scientific Discovery (LSDIF) has a Days Sales Outstanding of 9.13 as of Dec. 2023. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Lucy Scientific Discovery and its competitors.
Is Lucy Scientific Discovery's Days Sales Outstanding too high?
Lucy Scientific Discovery's current Days Sales Outstanding is 9.13. The Drug Manufacturers industry median Days Sales Outstanding is 71.98. Lucy Scientific Discovery's value of 9.13 is 87.3% below this industry median.
How does Lucy Scientific Discovery's Days Sales Outstanding compare to INQD and ZTS?
Lucy Scientific Discovery's Days Sales Outstanding of 9.13 can be compared against companies in the Drug Manufacturers industry. The industry median Days Sales Outstanding is 71.98. Lucy Scientific Discovery's value of 9.13 is 87.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Drug Manufacturers company?
The median Days Sales Outstanding among Drug Manufacturers companies is 71.98, based on 947 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lucy Scientific Discovery's current Days Sales Outstanding of 9.13 is 87.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Lucy Scientific Discovery and its competitors. For the Drug Manufacturers industry, the median Days Sales Outstanding is 71.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lucy Scientific Discovery's current Days Sales Outstanding is 9.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lucy Scientific Discovery stock overvalued right now?
Lucy Scientific Discovery (LSDIF) has a current Days Sales Outstanding of 9.13. The current Days Sales Outstanding is 9.13 and 87.3% below the Drug Manufacturers industry median of 71.98. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Lucy Scientific Discovery (LSDIF), the current Days Sales Outstanding is 9.13 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lucy Scientific Discovery Inc is an early-stage psychotropics contract manufacturing company focused on becoming the contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry. Its drug products are designed to treat a range of mental health and cognitive conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSDIF has been successfully added to your 
